Analysis

UiPath Stock Rises 22% in Four Days as Cash Position Offsets ARR Concerns

UiPath shares rose 22.5% in four days, fueled by a $1.42 billion cash position and buybacks, but net new ARR growth is slowing.

Daniel Marsh · · · 2 min read · 12 views
UiPath Stock Rises 22% in Four Days as Cash Position Offsets ARR Concerns
Mentioned in this article
APPN $23.75 +8.15% PATH $12.19 +4.91% PEGA $29.53 +3.25%

UiPath Inc (NYSE:PATH) shares continued their upward trajectory on Wednesday, gaining 2.5% to $12.50 during midday trading. This advance extended the company's four-day recovery to 22.5%, as the stock rebounded from recent lows.

The rally comes without any fresh corporate announcements or SEC filings from the automation software provider. The most recent official updates from UiPath were released on July 15 and July 14, leaving investors to assess the company's valuation based on its financial position and growth prospects.

UiPath's performance outpaced the broader software sector, with the iShares Expanded Tech-Software Sector ETF (IGV) rising only 6% over the same period. Among automation peers, Appian (APPN) surged 30.3%, while Pegasystems (PEGA) climbed 17.5%, indicating a focused recovery in automation stocks.

Balance Sheet Strength

UiPath reported $1.42 billion in cash and marketable securities as of April 30, representing approximately 21% of its current market capitalization. Adjusting for this cash hoard, the enterprise value stands at roughly $5.18 billion, which equates to about 2.9 times the midpoint of projected revenue guidance for fiscal 2027.

This valuation is challenged by growth expectations. The company's full-year forecast calls for approximately 10.4% revenue expansion, down from the 17% growth seen in the first quarter. The adjusted operating-income outlook of $430 million implies a margin of 24.2%, about 1.2 percentage points higher than fiscal 2026, suggesting that most valuation gains are coming from margin improvement rather than top-line growth.

ARR Growth Under Scrutiny

Annual recurring revenue (ARR) remains a critical metric. The second-quarter outlook indicates net new ARR between $28 million and $33 million, nearly matching the $31 million reported in the same quarter last year. However, this projected increase would represent a 33% to 43% decline compared to the first quarter's $49 million gain.

Chief Executive Daniel Dines stated in May that agentic products were "moving from pilot to production." Annualized recurring revenue for the first quarter increased by 12% to $1.901 billion, with dollar-based net retention at 109%, according to SEC filings.

Profitability and Buybacks

Profitability provides investors with flexibility. UiPath reported operating income of $28 million under GAAP, with operating cash flow of $132 million and adjusted free cash flow of $130 million. The company allocated $243.8 million to share repurchases in the quarter, amounting to 1.85 times its operating cash flow.

UiPath acquired 20.4 million shares at an average price of $11.47. On Wednesday, the shares were trading roughly 9% above that level. The diluted share count dropped 3.8% compared to the same period last year. However, cash and securities decreased to $1.42 billion in April from $1.69 billion in January, partly due to $149.4 million in acquisition expenditures.

The upcoming report needs to demonstrate that agentic deployments are driving an increase in new ARR. If not, the recovery will depend more on cash, margins, and share repurchases. There is still no evidence of accelerating demand.

This article is for informational purposes only and does not constitute financial advice or a recommendation to buy or sell any security. Market data may be delayed. Always conduct your own research and consult a licensed financial advisor before making investment decisions.

Related Articles

View All →